CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- 4 Open-market buy Chief Operating Officer bought 200,000 shares at $6.34 ($1,267,780)
- 4 Open-market buy 10% owner bought 300,000 shares at $7.26 ($2,176,530)
- 4 Open-market buy 10% owner bought 1,408,468 shares at $6.41 ($9,021,801)
- 4 Open-market buy Chief Financial Officer bought 85,000 shares at $5.79 ($492,150)
- 4 Open-market buy Director bought 10,000 shares at $8.54 ($85,400)
- 4 Open-market buy Director bought 20,000 shares at $9.05 ($181,000)
- 4 Open-market buy Chief Operating Officer bought 230,789 shares at $8.66 ($1,998,633)
- 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Option exercise Chief Financial Officer acquired 500,000 shares (option exercise)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 8 · 145 filings